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Psoriasis is a chronic inflammatory skin condition with significant physical and
psychosocial comorbidity. A workshop of leading experts in dermatology and psychology
with the purpose of better understanding the current role of psychological comorbidities
in psoriasis was held by the International Psoriasis Council in November 2013. The role of
stress reactivity with a focus on the hypothalamic-pituitary-adrenal axis was emphasized.
While cognitive behavioral therapy remains the most extensively studied and successful
treatment strategy in patients with psoriasis and various psychological comorbidities,
new and innovative interventions such as online-based therapies have recently emerged.
Strategies and recommendations toward approaching psychological comorbidities are
discussed.
Keywords: psoriasis, stress, depression, anxiety, psychological comorbidities, hypothalamic-pituitary-adrenal
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INTRODUCTION
Psoriasis is a chronic, relapsing and remitting inflammatory disease of the skin with a prevalence
of 2–3% worldwide (Koo, 1999). Chronic plaque psoriasis, the most common form of this disease,
is characterized by scaly, erythematous, and infiltrated skin lesions, which are often pruritic and
painful (Christophers and Mrowietz, 2003). Psoriasis can be a significantly disabling disease,
interfering with activities of daily life, increasing levels of social stigmatization, and generating
psychological distress. Stress is a well-known exacerbating factor of psoriasis (Farber and Nall,
1993). The interplay between stress and other psychological comorbidities with psoriasis has been
of common interest to both dermatologists and mental health professionals alike.
The International Psoriasis Council (IPC) is a dermatology-led, global non-profit organization
dedicated to innovation across the full spectrum of psoriasis through research, education, and
treatment. Recently, the IPC has led an initiative to better define the association of various
psychological comorbidities with psoriasis. In November 2013, a workshop was held in Boston,
MA, which assembled a panel of global dermatology and psychology experts, with the objective
to review the current research in the role of psychological comorbidities, focusing on stress and
the interplay of the hypothalamic-pituitary-adrenal axis (HPAA) in psoriasis. In addition, the
committee also sought to describe the current psychological treatment strategies that have been
studied in psoriatic patients with recommendations for clinical practice. The following report
synthesizes the presentations and panel discussions from this meeting.
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HPAA ACTIVITY AND STRESS REACTIVITY
IN PSORIASIS
Andrea Evers discussed the connection between stress reactivity
and psoriasis. While the role of stress in the escalation
of skin disease and psoriasis is a common patient-reported
phenomenon, there have been relatively few experimental studies
on the correlation between psoriasis and stress exposure (Fortune
et al., 2005). Prospective studies have shown that periods of high
stress moderate the disease course in psoriasis, with more daily
stressors predicting increased Psoriasis Area and Severity Index
(PASI) scores with itch in the following month. (Verhoeven et al.,
2009; Evers et al., 2010) One potential mediator of the stress
and skin disease relationship is the role of the HPAA, which
may be dysregulated in patients with chronic inflammatory
diseases. Gene expression analysis studies have shown increased
expression of several HPAA mediators in both lesional and non-
lesional psoriasis skin samples compared to normal skin controls
(Loite et al., 2013). Experimentally induced stress tests have
shown that cortisol levels in patients with psoriasis exposed to a
public speaking task are significantly more acutely elevated than
in healthy controls (de Brouwer et al., 2013b). This phenomenon
may be influenced by different patient characteristics, however,
as subgroups of patients who consider themselves highly stress
reactive actually have lower baseline and post stressful task
cortisol levels compared to those that do not describe themselves
as stress reactive. (Richards et al., 2005; Evers et al., 2010)
This attenuated adrenal activity has also been observed in
other chronic inflammatory diseases such as atopic dermatitis
and rheumatoid arthritis, and could potentially contribute to
the perpetuation of the inflammatory state in these diseases.
(Chikanza et al., 1992; Buske-Kirschbaum et al., 2002) This
particular subgroup of high stress responders who exhibit a
hypocortisolemic response to stress are speculated to also be
more likely to have more severe rebound flares of their psoriasis
following discontinuation of systemic corticosteroids (Richards
et al., 2005).
So is it possible to change the psychophysiological stress
response in psoriasis with stress-management treatment? New
research implies that stress relief interventions can lead to
changes in the cortisol responses of highly distressed individuals.
Stress management training has been shown to positively affect
the course of psoriasis and quality of life of patients in addition
to contributing to a reduction of treatment duration when used
in conjunction with certain mainstay therapies for psoriasis,
such as a phototherapy. (Kabat-Zinn et al., 1998; Fortune et al.,
2002) Healthy subjects who underwent resource-oriented stress
management training prior to an experimentally induced stress
task had significantly attenuated cortisol responses and stress
appraisals than controls (Storch et al., 2007). While the data for
psoriasis has been modest to date, immune modulation has been
observed in patients with rheumatoid arthritis who participated
in stress management training, with a significant reduction of
Il-8 cytokine levels at 2 month follow-up compared to a control
(de Brouwer et al., 2013a).Therapies targeting stress management
have therefore been a focus of adjunct treatment in these patients
in an effort to reduce flares.
Studies have shown that there is a lack of effective systematic
screening for subgroups at risk (e.g., highly distressed patients).
A questionnaire study of dermatologists in The Netherlands
demonstrated that on average, dermatologists referred only
eight patients per year to a psychologist or other psychosocial
professional and 50% of dermatologists have never referred
to a psychologist or other psychosocial therapist (Evers et al.,
2013). Countries, such as the Netherlands, have national
referral networks for psychosocial professionals with educational
programs and resources for referring providers. Examples of
tailored care approaches to stress-management were discussed.
One such approach is the use of E-health applications, which
are web-based programs that use online screening tools to
identify sub-groups within a population and then offer patient-
specific tailored training based on those subgroups. This
method may offer greater patient flexibility and financial and
time economization when access to a face-to-face specialized
cognitive behavioral therapist is limited. In target groups, such
as those with relatively severe adjustment problems who may
benefit from this type of intervention, web-based therapies
have shown to be effective in various psychological conditions
including anxiety and depression in addition to chronic somatic
conditions (Cuijpers et al., 2008). The implications for clinical
practice are thus, to reduce stress in these patients through
the establishment of trust in care, effective doctor-patient
communication, and providing adequate information of risk and
treatment options.
PSYCHOLOGICAL INTERVENTION IN
PSORIASIS
Elaborating further on treatment in the realm of psychological
comorbidities, Christine Bundy reviewed the currently available
psychological interventions for people with psoriasis. While a
range of psychological interventions have been used in this
population, there have been few high-quality studies comparing
their effectiveness in this population. Cognitive behavioral
therapy (CBT), including one-on-one, group-based, and online
programs, is probably the most widely studied treatment with
clear evidence that an emotion-focused CBT approach can have
a positive effect on psoriasis activity, distress, and quality of
life, especially if therapy is tailored to the individual. (Zachariae
et al., 1996; Fortune et al., 2002, 2004; Bundy et al., 2013)
Other cognitive-based approaches including education and self-
management, mindfulness, and psychotherapy have limited
supporting data due to poor quality studies. There is almost no
evidence to support claims that a purely educational approach
to patient management improves psychological outcomes. A
study by Bostoen and colleagues did show a relatively small
effect on PASI, DLQI, depression, physical activity, and smoking
cessation for a combined education and self-management
approach, however, inference is limited due to a small sample
size and a relatively unrealistic management strategy using
a multi-professional team of nine people for 2 h twice per
week for 3 months (Bostoen et al., 2012). Similarly, studies in
arousal management and mindfulness training are lacking in
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high-quality reporting and therefore, firm conclusions on their
effectiveness in treating patients with psoriasis with psychological
comorbidities cannot be confidently stated (Fordham et al.,
2013).
The importance of recognizing increased comorbidities
such as obesity, smoking and alcohol abuse in patients with
psoriasis were highlighted together with strategies in behavior
change therapies. Motivational interviewing including self-
management does effect behavior change in patients with
other long-term conditions such as cardiovascular and diabetes
(Knight et al., 2006; Phillips et al., 2012). Studies in weight
reduction using a very low energy diet showed significant
weight reduction as well as trends in PASI improvement and
significant reductions in DLQI in overweight patients with
psoriasis (Jensen et al., 2013). Unfortunately, there are no reliable
studies in alcohol reduction and smoking cessation in this
population.
In summary, a tailored CBT approach has been most
consistently effective in managing distress in patients with
psoriasis. However, CBT has high rates of attrition even with
online delivery and the clinical dermatology workforce is not
skilled to deliver CBT interventions with too few psychologists
available. A combination strategy of both CBT and behavior
change therapy has potential to optimally treat this population.
More high quality trials with larger samples and consistent
outcome measures on behavior change interventions focusing
on weight, physical activity, alcohol use, and smoking are
needed in order to manage cardiovascular disease and diabetes
risk. Accessible interventions targeting both psychological and
physical outcomes that work in a standard clinic setting are
needed. Dermatologists need to be familiar with all available
therapeutic options and refer appropriately. Lastly, staff training
to support specialist interventions is recommended with the
emphasis on demonstrating the fidelity of interventions and
consistency of approach among staff.
In conclusion, psoriasis is a chronic disease that can
carry a significant psychological comorbidity burden. Increased
stress has been shown to have a negative impact on skin
involvement, further potentiating the disease process. New
research suggests that this clinical response may be related
to cortisol dysregulation within the HPAA and that the
psychophysiological stress response in patients with psoriasis
may be improved with stress-management treatment. E-health
therapy, among other approaches, for example, may be a flexible,
patient-tailored approach to stress reduction in this population.
A multidisciplinary approach utilizing both dermatologic care
with screening of comorbidities and early referral access to
psychological intervention may be crucial and should be
encouraged toward optimal management of this disease.
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